Sign up
Log in
Snowflake, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Share
Listen to the news

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday.

Shares of Snowflake Inc (NYSE:SNOW) fell sharply in pre-market trading after posting quarterly results.

Snowflake delivered third-quarter revenue of $1.21 billion, beating analyst estimates of $1.18 billion, according to Benzinga Pro. The AI data cloud company reported adjusted earnings of 35 cents per share for the period, beating analyst estimates of 31 cents per share.

Snowflake shares dipped 8.6% to $241.85 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

  • Net Lease Office Properties (NYSE:NLOP) shares dipped 14.7% to $25.19 in pre-market trading.
  • Symbotic Inc (NASDAQ:SYM) fell 10.5% to $65.50 in pre-market trading after the company announced a 10 million share offering, including 6.5 million shares from the company and 3.5 million from a selling stockholder.
  • Capricor Therapeutics Inc (NASDAQ:CAPR) dipped 8.4% to $27.45 in pre-market trading after jumping 371% on Wednesday. The company announced topline results from its Phase 3 HOPE-3 Trial evaluating deramiocel cell therapy for Duchenne Muscular Dystrophy met its primary endpoint and secondary cardiac endpoint.
  • ADC Therapeutics SA (NYSE:ADCT) declined 8.1% to $3.63 in pre-market trading. ADC Therapeutics shares dipped 14% on Wednesday after the company reported updated data from its LOTIS-7 trial evaluating Zynlonta in combination with Glofitamab in relapsed/refractory DLBCL patients.
  • Lineage Cell Therapeutics Inc (NYSE:LCTX) fell 7.1% to $1.56 in pre-market trading.
  • Koninklijke Philips NV (NYSE:PHG) fell 6.8% to $26.11 in pre-market trading.
  • Omeros Corp (NASDAQ:OMER) declined 4.2% to $10.18 in pre-market trading.
  • Methanex Corp (NASDAQ:MEOH) fell 3.8% to $35.95 in pre-market trading.

Now Read This:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.